FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008909910> ?p ?o ?g. }

• W2008909910 endingPage "S176" @default.
• W2008909910 startingPage "S176" @default.
• W2008909910 abstract "To evaluate biochemical control rates (BCR) and identify prognostic factors for patients (pts) with localized prostate cancer treated with conventional-dose 3-D conformal radiotherapy (3D-CRT), high-dose intensity-modulated radiotherapy (IMRT), or permanent transperineal brachytherapy (BRT). 684 pts. who received RT at Mayo Clinic Arizona between May of 1993 and July of 2004 are included in this analysis. Of these patients, 270 received 3D-CRT, 145 received IMRT, and 269 received BRT (225 pts with BRT alone & 44 pts with external beam RT (XRT) +BRT as a boost). The distribution of T-stages included: T-1:221 pts, T-2:432 pts, & T-3:31 pts. Pre-treatment PSA levels ranged from 0.5–197 (median:7) and Gleason Scores ranged from 2–10 (median:6). Adjuvant androgen deprivation therapy was administered to 175 (26%) of the 684 pts. The 3D-CRT pts received a median dose of 68.4 Gy (range:66–71 Gy) and the IMRT pts received a median dose of 75.6 Gy (range, 70.2–77.4 Gy). The BRT pts who received I-125 alone or Pd-103 alone had a prescribed dose of 144 Gy or 120 Gy, respectively. Pts who received combined XRT and BRT boost had 45 Gy XRT followed 110 Gy with I-125 or 90 Gy with Pd-103. Univariate analysis was performed with the log-rank test and multivariate analysis with the Cox Proportional Hazards Model. Biochemical failure was defined a rise in PSA of 2.0 above the nadir. Follow up ranged from 3–121 months (median: 55 mo). The 4-year biochemical control rates (BCR) were 82% for 3-DCRT, 91% for IMRT, 95% for BRT alone, and 94% for XRT+BRT (p < 0.0001). On univariate analysis, the following factors were found to be significantly associated with BCR's: T-stage (p < 0.0001), Gleason Score (p < 0.0001), pre-RT PSA levels (p < 0.0001), Memorial Sloan Kettering Cancer Center Risk Group (p < 0.0001), and perineural tumor invasion (p = 0.0003). The use of adjuvant androgen deprivation therapy was not associated with BCR's (p = 0.5). Multivariate analysis was performed excluding the risk grouping because it contains elements of T-stage, PSA level, and Gleason Score & would confound the analysis. The multivariate analysis revealed the following factors to be associated with biochemical control: pre-treatment PSA level (p = 0.003), Gleason Score (p = 0.0006), perineural invasion (p = 0.008), and treatment modality (p < 0.0001). If one excluded the pts treated with 3-DCRT from the multivariate analysis, the effect of treatment modality on biochemical control became non-significant (p = 0.08). The 4-year overall survival of the entire group was 97%. Biochemical control rates are associated with Gleason Score, pre-RT PSA level, and perineural involvement. These factors can be used to create an excellent method of predicting treatment outcome and stratifying patients. In addition, higher-dose RT modalities such as brachytherapy or high-dose IMRT appear superior to conventional-dose 3-DCRT." @default.
• W2008909910 created "2016-06-24" @default.
• W2008909910 creator A5020610248 @default.
• W2008909910 creator A5030089962 @default.
• W2008909910 creator A5032959560 @default.
• W2008909910 creator A5062848479 @default.
• W2008909910 date "2007-11-01" @default.
• W2008909910 modified "2023-09-23" @default.
• W2008909910 title "Comparison of the Outcomes of Various Radiation Treatment Modalities for Prostate Cancer" @default.
• W2008909910 doi "https://doi.org/10.1016/j.ijrobp.2007.07.319" @default.
• W2008909910 hasPublicationYear "2007" @default.
• W2008909910 type Work @default.
• W2008909910 sameAs 2008909910 @default.
• W2008909910 citedByCount "0" @default.
• W2008909910 crossrefType "journal-article" @default.
• W2008909910 hasAuthorship W2008909910A5020610248 @default.
• W2008909910 hasAuthorship W2008909910A5030089962 @default.
• W2008909910 hasAuthorship W2008909910A5032959560 @default.
• W2008909910 hasAuthorship W2008909910A5062848479 @default.
• W2008909910 hasBestOaLocation W20089099101 @default.
• W2008909910 hasConcept C121608353 @default.
• W2008909910 hasConcept C126322002 @default.
• W2008909910 hasConcept C126894567 @default.
• W2008909910 hasConcept C144301174 @default.
• W2008909910 hasConcept C2777416452 @default.
• W2008909910 hasConcept C2777899217 @default.
• W2008909910 hasConcept C2779709957 @default.
• W2008909910 hasConcept C2780192828 @default.
• W2008909910 hasConcept C2989005 @default.
• W2008909910 hasConcept C3019894029 @default.
• W2008909910 hasConcept C38180746 @default.
• W2008909910 hasConcept C509974204 @default.
• W2008909910 hasConcept C71924100 @default.
• W2008909910 hasConceptScore W2008909910C121608353 @default.
• W2008909910 hasConceptScore W2008909910C126322002 @default.
• W2008909910 hasConceptScore W2008909910C126894567 @default.
• W2008909910 hasConceptScore W2008909910C144301174 @default.
• W2008909910 hasConceptScore W2008909910C2777416452 @default.
• W2008909910 hasConceptScore W2008909910C2777899217 @default.
• W2008909910 hasConceptScore W2008909910C2779709957 @default.
• W2008909910 hasConceptScore W2008909910C2780192828 @default.
• W2008909910 hasConceptScore W2008909910C2989005 @default.
• W2008909910 hasConceptScore W2008909910C3019894029 @default.
• W2008909910 hasConceptScore W2008909910C38180746 @default.
• W2008909910 hasConceptScore W2008909910C509974204 @default.
• W2008909910 hasConceptScore W2008909910C71924100 @default.
• W2008909910 hasIssue "3" @default.
• W2008909910 hasLocation W20089099101 @default.
• W2008909910 hasOpenAccess W2008909910 @default.
• W2008909910 hasPrimaryLocation W20089099101 @default.
• W2008909910 hasRelatedWork W2074328629 @default.
• W2008909910 hasRelatedWork W2083802215 @default.
• W2008909910 hasRelatedWork W2138863125 @default.
• W2008909910 hasRelatedWork W2192988598 @default.
• W2008909910 hasRelatedWork W2365726090 @default.
• W2008909910 hasRelatedWork W2579941273 @default.
• W2008909910 hasRelatedWork W2597301728 @default.
• W2008909910 hasRelatedWork W2789553788 @default.
• W2008909910 hasRelatedWork W2946095553 @default.
• W2008909910 hasRelatedWork W4383700443 @default.
• W2008909910 hasVolume "69" @default.
• W2008909910 isParatext "false" @default.
• W2008909910 isRetracted "false" @default.
• W2008909910 magId "2008909910" @default.
• W2008909910 workType "article" @default.